From this foundation, a recent genome-wide cross-trait analysis indicated AD and gastrointestinal tract disorders share several loci including PDE4B and BRINP3 that are promising candidates as underlying gut–brain mechanisms related to AD and IBD [56]. Here, BRINP3 is linked to irritable bowel syndrome.